These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530 [TBL] [Abstract][Full Text] [Related]
3. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423 [TBL] [Abstract][Full Text] [Related]
4. INTERMACS: interval analysis of registry data. Holman WL; Pae WE; Teutenberg JJ; Acker MA; Naftel DC; Sun BC; Milano CA; Kirklin JK J Am Coll Surg; 2009 May; 208(5):755-61; discussion 761-2. PubMed ID: 19476831 [TBL] [Abstract][Full Text] [Related]
5. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946 [TBL] [Abstract][Full Text] [Related]
6. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011. Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245 [TBL] [Abstract][Full Text] [Related]
7. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ; J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950 [TBL] [Abstract][Full Text] [Related]
9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. Alba AC; Rao V; Ivanov J; Ross HJ; Delgado DH J Heart Lung Transplant; 2009 Aug; 28(8):827-33. PubMed ID: 19632580 [TBL] [Abstract][Full Text] [Related]
11. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570 [TBL] [Abstract][Full Text] [Related]